Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2005
10/05/2005EP1581505A1 Pyridazinone derivatives as gsk-3beta inhibitors
10/05/2005EP1581488A1 Inhibitors of tace
10/05/2005EP1581484A1 Hydroxamic acid derivatives having anti-inflammatory action
10/05/2005EP1581478A1 Dhodh-inhibitors and method for their identification
10/05/2005EP1581471A1 Cyclopentenone derivatives for cancer therapy
10/05/2005EP1581309A2 Kinase modulators
10/05/2005EP1581257A1 A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis
10/05/2005EP1581238A1 Improvements in or relating to immune functions
10/05/2005EP1581228A1 Treatment of von hippel lindau disease
10/05/2005EP1581218A1 Epothilone analogs for site specific delivery in the treatment of proliferative diseases
10/05/2005EP1581165A2 Novel factor viia inhibiting compounds
10/05/2005EP1511475B1 A herbal molecule as potential anti-leukemic drug
10/05/2005EP1419154B1 Rapamycin 29-enols
10/05/2005EP1370271B1 A process for the manufacture of a herbal composition comprising a matrine
10/05/2005EP1294370B1 Triterpenoid derivatives
10/05/2005EP1263430B1 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases
10/05/2005EP1248654B1 Intra-tumoral administration of il-12 encoding naked nucleic acid molecules
10/05/2005EP1233950B1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS
10/05/2005EP1202733B1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
10/05/2005EP1183233B1 Bradykinin receptor antagonists
10/05/2005EP1001977B1 Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors
10/05/2005CN1678734A Differentiation modulating agents and uses therefor
10/05/2005CN1678633A Anti-IGF-I receptor antibody
10/05/2005CN1678628A Stress proteins and peptides and methods of use thereof
10/05/2005CN1678627A Novel depsipeptide compound
10/05/2005CN1678626A Estrieno[3, 2-b]/[3, 4-c]pyrrole derivatives useful as modulators of the estrogen receptors
10/05/2005CN1678625A Humanized anti-lymphotoyin beta receptor antibodies
10/05/2005CN1678607A Nitrogen-containing aromatic ring derivatives
10/05/2005CN1678606A Novel crystals
10/05/2005CN1678604A Novel benzoimidazole derivatives useful as antiproliferative agents
10/05/2005CN1678590A Amide derivative and medicine
10/05/2005CN1678589A Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them
10/05/2005CN1678586A 取代的喹啉ccr5受体拮抗剂 Substituted quinoline ccr5 receptor antagonist
10/05/2005CN1678573A Diarylurea derivatives and their use as chloride channel blockers
10/05/2005CN1678572A Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
10/05/2005CN1678350A Remedy
10/05/2005CN1678348A Compositions and methods for therapeutic treatment
10/05/2005CN1678347A Antibodies and uses thereof
10/05/2005CN1678344A Human papilloma virus treatment
10/05/2005CN1678338A Method and composition for regulating the activity of regulatory T cells
10/05/2005CN1678337A Amelioration of effects of cigarette smoke
10/05/2005CN1678335A Agaricus blazei murill extract capable of preventing cancer induction or metastasis
10/05/2005CN1678334A New plant based agents as bioavailability/bioefficacy enhancers for drugs and nutraceuticals
10/05/2005CN1678332A Novel therapeutic use of polypodium extracts
10/05/2005CN1678314A Glycinamide derivatives as raf-kinase inhibitors
10/05/2005CN1678312A Use of CCI-779 as an antineoplastic agent
10/05/2005CN1678304A PKC activation as a means for enhancing aAPP-a secretion and improving cognition using bryostatin type compounds
10/05/2005CN1678300A A pharmaceutical composition useful for treating chronic myeloid leukemia
10/05/2005CN1678188A Nucleic acid compositions for stimulating immune responses
10/05/2005CN1676533A Gecko polysaccharide, and its preparing method and pharmaceutical use
10/05/2005CN1676531A Recombinant immunotoxin based on pseudomonas exotoxin containing (Arg) 9 peptide segment
10/05/2005CN1676530A Matrimony vine arabinogalactan protein, and its preparing process, use and composition
10/05/2005CN1676525A Hydrophilic polymer-thunder good vine extract binding substance and its medicinal composition
10/05/2005CN1676521A Kuh-seng ketone and its derivative and the like and use in preparing anti-tumor medicine
10/05/2005CN1676520A Kuh-seng flavone extract and preparation and use thereof
10/05/2005CN1676162A Thymic penta peptide injection liquid
10/05/2005CN1676126A Method for preparing anticancer, cancer-preventing ocean active medicine
10/05/2005CN1676125A Nano-level emulsion containing taxine or hard-soluble medicine
10/05/2005CN1676124A Antibody chemotherapy-medicine
10/05/2005CN1221663C High effective expression of recombined human internal inhibition factor
10/05/2005CN1221565C Peptides and their derivatives thereof showing cell attachment, spreading and detachment activity
10/05/2005CN1221560C Preparation of oxaliplatin
10/05/2005CN1221544C Pyrazole cyclic AMP-specific PDE inhibitors
10/05/2005CN1221540C Chiral sugarapple lactone compound modified by ether bond, its synthesis method and application
10/05/2005CN1221535C Spiroimidazolidine derivatives, their prepn. their use and pharmaceutical preparation comprising them
10/05/2005CN1221533C 7-amino-1H-indole derivatives
10/05/2005CN1221527C Novel crystal of stilbene derivative and process for producing the same
10/05/2005CN1221285C Method for preparing genetically engineered nano vaccine for malignant tumour, such as liver cancer, stomach cancer and breast cancer
10/05/2005CN1221271C Chinese medicinal external preparation for treating ulcer of lower limbs
10/05/2005CN1221262C Phthalazine derivatives for treating inflammatory diseases
10/05/2005CN1221182C Synanthrin products with improved nutritional properties
10/04/2005US6951937 Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof
10/04/2005US6951923 For regenerating tissues; antiaging agents; medical diagnosis; monitoring chemotherapy
10/04/2005US6951889 7-acetamidinyl derivatives
10/04/2005US6951887 Lipoic acid derivatives and their use in treatment of disease
10/04/2005US6951883 2H-1-benzopyran derivatives processes for their preparation and pharmaceutical compositions thereof
10/04/2005US6951879 Heteroaromate OSC inhibitors
10/04/2005US6951876 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents
10/04/2005US6951874 Compounds
10/04/2005US6951858 Substituted 1,2,4-triazine-3,5-diones; male and female sex hormone related conditions
10/04/2005US6951856 Substituted pyrimidine-sulfonamide derivatives are used as endothelin receptor antagonists
10/04/2005US6951855 vascular damaging agents
10/04/2005US6951853 DNA sequence selective agents as potential antitumor compounds
10/04/2005US6951852 osteoarthritis; little to no intrinsic estrogenicity; antagonizes the effects of 17 beta -estradiol with minimal uterine stimulation; bone loss inhibitor
10/04/2005US6951756 Closure of bacterial ghost
10/04/2005US6951735 Death domain containing receptors
10/04/2005US6951640 Imaging tumors using organometallic porphyrin
10/04/2005CA2262862C Angiogenic inhibitory compounds
10/04/2005CA2152771C 7-o-ethers of taxane derivatives
10/02/2005CA2461375A1 Cea binding agents compositions to reverse cea-mediated tumorigenic effects on human cancer cells, restore sensitivity to drug induced apoptosis and uses thereof
09/2005
09/29/2005WO2005090579A1 Modified bouganin proteins, cytotoxins and methods and uses thereof
09/29/2005WO2005090575A1 Glycosylation variants of ricin-like proteins
09/29/2005WO2005090574A1 Vascular endothelial growth inhibiting gene
09/29/2005WO2005090405A1 Subtype of humanized antibody against interleukin-6 receptor
09/29/2005WO2005090388A1 Alpha helical mimics, their uses and methods for their production
09/29/2005WO2005090341A1 Azabicyclooctan-3-one derivatives and use thereof
09/29/2005WO2005090326A1 Antibiotic fki-1778 and process for producing the same
09/29/2005WO2005090298A1 Sulphonamide derivatives
09/29/2005WO2005090297A1 Sulphonamide derivatives
09/29/2005WO2005089802A1 Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient
1 ... 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 ... 2211